T1	CHEM 15 24	glutamina
#1	AnnotatorNotes T1	C0017797; glutamine; Amino Acid, Peptide, or Protein · Biologically Active Substance · Pharmacologic Substance
T2	PROC 61 86	trasplante de médula ósea
#2	AnnotatorNotes T2	C0005961; Bone Marrow Transplantation; Therapeutic or Preventive Procedure
T3	DISO 454 473	estados catabólicos
#3	AnnotatorNotes T3	C0853892; Catabolic state; Disease or Syndrome
T4	PROC 91 116	Trasplante de Médula Ósea
#4	AnnotatorNotes T4	C0005961; Bone Marrow Transplantation; Therapeutic or Preventive Procedure
T5	PROC 118 121	TMO
#5	AnnotatorNotes T5	C0005961; Bone Marrow Transplantation; Therapeutic or Preventive Procedure
T6	PROC 130 141	tratamiento
#6	AnnotatorNotes T6	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T7	DISO 159 192	neoplasias malignas hematológicas
T8	DISO 195 210	tumores sólidos
#7	AnnotatorNotes T8	C0280100; Solid Neoplasm; Neoplastic Process
T9	PROC 215 228	quimioterapia
#8	AnnotatorNotes T9	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure + C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T10	PROC 233 245	radioterapia
#9	AnnotatorNotes T10	C1522449; Therapeutic radiology procedure; Therapeutic or Preventive Procedure
T11	DISO 302 321	efectos secundarios
#10	AnnotatorNotes T11	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T12	DISO 335 352	estrés metabólico
T13	CHEM 357 366	glutamina
#11	AnnotatorNotes T13	C0017797; glutamine; Amino Acid, Peptide, or Protein · Biologically Active Substance · Pharmacologic Substance
T14	CHEM 390 400	aminoácido
#12	AnnotatorNotes T14	C0002520; Amino Acids; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Biologically Active Substance
T15	CHEM 1312 1332	L-alanil-L-glutamina
#13	AnnotatorNotes T15	C0051080; alanylglutamine; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Biologically Active Substance
T16	PROC 534 545	tratamiento
#14	AnnotatorNotes T16	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T17	PROC 550 588	Nutrición Parenteral (NP) suplementada
T18	CHEM 593 602	glutamina
#15	AnnotatorNotes T18	C0017797; glutamine; Amino Acid, Peptide, or Protein · Biologically Active Substance · Pharmacologic Substance
T19	PROC 674 677	TMO
#16	AnnotatorNotes T19	C0005961; Bone Marrow Transplantation; Therapeutic or Preventive Procedure
T20	DISO 711 725	complicaciones
#17	AnnotatorNotes T20	C0009566; Complication; Pathologic Function
T21	PROC 737 770	valoración del estado nutricional
#18	AnnotatorNotes T21	C0028708; Nutrition Assessment; Diagnostic Procedure
T22	PROC 831 842	transplante
#19	AnnotatorNotes T22	C0040732; Transplantation; Therapeutic or Preventive Procedure
T24	PROC 888 964	Ensayo Clínico en fase IV, aleatorizado, doble ciego, paralelo y unicéntrico
T25	PROC 1102 1114	diagnósticos
#20	AnnotatorNotes T25	C0011900; Diagnosis; Diagnostic Procedure
T26	DISO 1116 1125	leucemias
#21	AnnotatorNotes T26	C0023418; leukemia; Neoplastic Process
T27	DISO 1127 1135	linfomas
#22	AnnotatorNotes T27	C0024299; Lymphoma; Neoplastic Process
T28	DISO 1138 1153	tumores sólidos
#23	AnnotatorNotes T28	C0280100; Solid Neoplasm; Neoplastic Process
T29	PROC 1156 1166	ingresados
#24	AnnotatorNotes T29	C0021629; Institutionalization; Health Care Activity | C0184666; Hospital admission; Health Care Activity
T30	PROC 1265 1280	NP suplementada
T31	CHEM 1285 1294	glutamina
#25	AnnotatorNotes T31	C0017797; glutamine; Amino Acid, Peptide, or Protein · Biologically Active Substance · Pharmacologic Substance
T32	PROC 1358 1369	NP Estándar
T33	PROC 1550 1552	NP
#26	AnnotatorNotes T33	C0030547; Parenteral Nutrition; Therapeutic or Preventive Procedure | C0204706; Parenteral alimentation procedure; Therapeutic or Preventive Procedure | C1527385; Parenteral Feeding; Therapeutic or Preventive Procedure
T34	PROC 1559 1570	tratamiento
#27	AnnotatorNotes T34	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T35	PROC 1659 1666	terapia
#28	AnnotatorNotes T35	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T36	PROC 1711 1714	TMO
#29	AnnotatorNotes T36	C0005961; Bone Marrow Transplantation; Therapeutic or Preventive Procedure
T37	CHEM 1786 1795	glutamina
#30	AnnotatorNotes T37	C0017797; glutamine; Amino Acid, Peptide, or Protein · Biologically Active Substance · Pharmacologic Substance
T38	CHEM 1828 1837	glutamina
#31	AnnotatorNotes T38	C0017797; glutamine; Amino Acid, Peptide, or Protein · Biologically Active Substance · Pharmacologic Substance
T39	ANAT 75 86	médula ósea
#32	AnnotatorNotes T39	C0005953; Bone Marrow; Tissue
T40	PROC 625 644	soporte nutricional
#33	AnnotatorNotes T40	C0242739; Nutritional Support; Therapeutic or Preventive Procedure
T41	ANAT 105 116	Médula Ósea
#34	AnnotatorNotes T41	C0005953; Bone Marrow; Tissue
T42	PROC 1767 1781	suplementación
#35	AnnotatorNotes T42	C0242297; Dietary Supplementation; Therapeutic or Preventive Procedure
T43	Route 25 35	parenteral
#36	AnnotatorNotes T43	C1518896; Parenteral Route of Drug Administration; Functional Concept
T44	LIVB 39 48	pacientes
#37	AnnotatorNotes T44	C0030705; Patients; Patient or Disabled Group
T45	LIVB 284 293	pacientes
#38	AnnotatorNotes T45	C0030705; Patients; Patient or Disabled Group
T47	Route 560 570	Parenteral
#39	AnnotatorNotes T47	C1518896; Parenteral Route of Drug Administration; Functional Concept
T49	LIVB 660 669	pacientes
#40	AnnotatorNotes T49	C0030705; Patients; Patient or Disabled Group
T50	Duration 792 803	los 6 meses
T52	LIVB 994 1003	pacientes
#41	AnnotatorNotes T52	C0030705; Patients; Patient or Disabled Group
T53	LIVB 1023 1030	mujeres
#42	AnnotatorNotes T53	C0043210; Woman; Population Group
T54	Age 1056 1072	entre 21-63 años
T55	LIVB 1228 1237	pacientes
#43	AnnotatorNotes T55	C0030705; Patients; Patient or Disabled Group
T56	Dose 1296 1304	0,4 g/kg
T57	Frequency 1304 1308	/día
T61	LIVB 1633 1642	pacientes
#44	AnnotatorNotes T61	C0030705; Patients; Patient or Disabled Group
T62	PHYS 1671 1677;1688 1698	efecto catabólico
#45	AnnotatorNotes T62	C1516314; Catabolic process; Physiologic Function (?)
T66	PHYS 550 559	Nutrición
#46	AnnotatorNotes T66	C1442959; Nutrition function; Organism Function
T46	PHYS 858 865	ingesta
#47	AnnotatorNotes T46	C0232478; Ingestion; Biologic Function
T48	LIVB 1009 1016	varones
#48	AnnotatorNotes T48	C0025266; Male population group; Population Group
T23	PHYS 462 473	catabólicos
#49	AnnotatorNotes T23	C0699900; Catabolism; Organism Function
T51	PHYS 342 352	metabólico
#50	AnnotatorNotes T51	C0025519; Metabolism; Organism Function
T58	PROC 1606 1624	estado nutricional
#51	AnnotatorNotes T58	C0028708; Nutrition Assessment; Diagnostic Procedure
T59	CONC 1405 1416	diferencias
A1	Assertion T59 Negated
#52	AnnotatorNotes T59	C1705241; Delta (difference); Quantitative Concept
T60	Neg_cue 1384 1386	No
R1	Negation Arg1:T60 Arg2:T59	
T63	Neg_cue 1723 1725	no
T64	CONC 1752 1760	eficacia
A2	Assertion T64 Negated
#53	AnnotatorNotes T64	C1280519; Effectiveness; Qualitative Concept
R2	Negation Arg1:T63 Arg2:T64	
T65	Observation 1 8	Efectos
#54	AnnotatorNotes T65	C1518681; Outcome of Therapy; Finding (?)
R3	Causes Arg1:T1 Arg2:T65	
R4	Has_Route_or_Mode Arg1:T1 Arg2:T43	
R5	Experiences Arg1:T44 Arg2:T65	
R6	Experiences Arg1:T44 Arg2:T1	
R7	Experiences Arg1:T44 Arg2:T2	
R8	Used_for Arg1:T39 Arg2:T2	
R9	Used_for Arg1:T41 Arg2:T4	
R10	Used_for Arg1:T41 Arg2:T5	
R11	Experiences Arg1:T45 Arg2:T9	
R12	Experiences Arg1:T45 Arg2:T10	
R13	Experiences Arg1:T45 Arg2:T11	
R14	Experiences Arg1:T45 Arg2:T12	
R15	Overlap Arg1:T12 Arg2:T51	
T67	Quantifier_or_Qualifier 330 334	alto
#55	AnnotatorNotes T67	C0205250; High; Qualitative Concept
R16	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T67	
R17	Causes Arg1:T9 Arg2:T11	
R18	Causes Arg1:T10 Arg2:T11	
R19	Overlap Arg1:T11 Arg2:T12	
T68	Quantifier_or_Qualifier 474 481	severos
#56	AnnotatorNotes T68	C1547227; Severe - Severity of Illness Code; Intellectual Product
R20	Has_Quantifier_or_Qualifier Arg1:T3 Arg2:T68	
R21	Overlap Arg1:T3 Arg2:T23	
R22	Has_Route_or_Mode Arg1:T17 Arg2:T47	
R23	Combined_with Arg1:T17 Arg2:T18	
T69	Observation 523 529	efecto
#57	AnnotatorNotes T69	C1518681; Outcome of Therapy; Finding (?)
R24	Causes Arg1:T16 Arg2:T69	
R25	Causes Arg1:T17 Arg2:T69	
R26	Experiences Arg1:T49 Arg2:T19	
R27	Experiences Arg1:T49 Arg2:T40	
R28	Experiences Arg1:T49 Arg2:T17	
R29	Experiences Arg1:T49 Arg2:T16	
R30	Experiences Arg1:T49 Arg2:T69	
T70	CONC 772 789	evolución clínica
#58	AnnotatorNotes T70	C0449259; Clinical course; Temporal Concept
R31	Has_Duration_or_Interval Arg1:T70 Arg2:T50	
R32	Has_Age Arg1:T53 Arg2:T54	
R33	Has_Age Arg1:T48 Arg2:T54	
R34	Has_Age Arg1:T52 Arg2:T54	
R35	Experiences Arg1:T52 Arg2:T29	
R36	Experiences Arg1:T48 Arg2:T29	
R37	Experiences Arg1:T53 Arg2:T29	
R38	Experiences Arg1:T52 Arg2:T28	
R39	Experiences Arg1:T48 Arg2:T28	
R40	Experiences Arg1:T53 Arg2:T28	
R41	Experiences Arg1:T52 Arg2:T27	
R42	Experiences Arg1:T48 Arg2:T27	
R43	Experiences Arg1:T53 Arg2:T27	
R44	Combined_with Arg1:T30 Arg2:T31	
R45	Has_Dose_or_Strength Arg1:T31 Arg2:T56	
R46	Has_Frequency Arg1:T31 Arg2:T57	
R47	Experiences Arg1:T55 Arg2:T30	
R48	Experiences Arg1:T55 Arg2:T32	
R49	Has_Frequency Arg1:T15 Arg2:T57	
R50	Has_Dose_or_Strength Arg1:T15 Arg2:T56	
R51	Combined_with Arg1:T30 Arg2:T15	
T71	CONC 1439 1445;1458 1469	inicio del estudio
#59	AnnotatorNotes T71	C4684789; Study Start; Temporal Concept
R52	Overlap Arg1:T59 Arg2:T71	
T72	CONC 1452 1469	final del estudio
#60	AnnotatorNotes T72	C2983670; Study End Date; Temporal Concept
R53	Overlap Arg1:T59 Arg2:T72	
R54	Experiences Arg1:T61 Arg2:T58	
R55	Experiences Arg1:T61 Arg2:T34	
R56	Experiences Arg1:T61 Arg2:T33	
T73	Quantifier_or_Qualifier 1678 1687	altamente
#61	AnnotatorNotes T73	C0205250; High; Qualitative Concept
R57	Has_Quantifier_or_Qualifier Arg1:T62 Arg2:T73	
R58	Causes Arg1:T35 Arg2:T62	
R59	Experiences Arg1:T61 Arg2:T35	
R60	Causes Arg1:T36 Arg2:T35	
R61	Experiences Arg1:T61 Arg2:T36	
R62	Experiences Arg1:T61 Arg2:T62	
R64	Used_for Arg1:T37 Arg2:T42	
R65	Used_for Arg1:T38 Arg2:T42	
T74	Quantifier_or_Qualifier 866 870	oral
#62	AnnotatorNotes T74	C0442027; Oral; Spatial Concept
R66	Has_Quantifier_or_Qualifier Arg1:T46 Arg2:T74	
T75	Quantifier_or_Qualifier 1417 1431	significativas
A3	Assertion T75 Negated
#63	AnnotatorNotes T75	C0750502; Significant; Idea or Concept
R67	Has_Quantifier_or_Qualifier Arg1:T59 Arg2:T75	
R68	Negation Arg1:T60 Arg2:T75	
#64	AnnotatorNotes T7	C0376545; Hematologic Neoplasms; Neoplastic Process
A4	Experiencer T44 Patient
A5	Experiencer T45 Patient
A6	Experiencer T49 Patient
A7	Experiencer T52 Patient
A8	Experiencer T48 Patient
A9	Experiencer T53 Patient
A10	Experiencer T55 Patient
A11	Experiencer T61 Patient
